Show simple item record

dc.contributor.advisorAbbasalizadeh, Fatemeh
dc.contributor.authorEbrahimzadeh, Negar
dc.date.accessioned2019-12-30T06:53:35Z
dc.date.available2019-12-30T06:53:35Z
dc.date.issued2019en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/61204
dc.description.abstractObjective: To assess the feasibility of adding letrozole to the standard regimen of mifepristone and misoprostol for termination of pregnancy in second-trimester. Annually 2% of women who are in fertility age terminate their pregnancies in legal manner.12% of abortion are done after 1th trimester that 95 % of them are done surgically. Misoprostol the E1 prostaglandin analoge using in prevention of stomach and deodenal ulcer, is used for abortion and termination of pregnancy.Letrozole is a third-generation aromatase inhibitor which is used to treat estrogen-dependent breast cancer.letrosole inhibit the convertion of testostrone to estrogen. Material: In this study 86 pregnant women were studied whom 43 cases were in misoprostol and placebo group and 43 of them were in letrozol and misoprostol group. Results: There was no difference between the two regimens in terms of the induction-to-abortion intervals and non of them need to curtage.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.subjectAbortionen_US
dc.subjectmedical abortionen_US
dc.subject2th trimester of pregnancyen_US
dc.subjectletrozolen_US
dc.subjectmisoprostolen_US
dc.subjectcurtageen_US
dc.titleThe effect of letrozole with misoprostol on induced abortion in the second trimesteren_US
dc.typeThesisen_US
dc.contributor.supervisorAbbasalizadeh, Shamsi
dc.identifier.docno609364en_US
dc.identifier.callno9364en_US
dc.description.disciplineGynecologyen_US
dc.description.degreeSpecialty Degreeen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record